| Arnold Seid Md Inc | |
|
960 Center St Ste 7 Wahiawa HI 96786-2038 | |
| (808) 621-6511 | |
| (808) 622-9088 |
| Full Name | Arnold Seid Md Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 960 Center St Ste 7, Wahiawa, Hawaii |
| Authorized Official Name and Position | Arnold Seid (PHYSICIAN) |
| Authorized Official Contact | 8086216511 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Arnold Seid Md Inc Po Box 2257 Honolulu HI 96804-2257 Ph: () - | Arnold Seid Md Inc 960 Center St Ste 7 Wahiawa HI 96786-2038 Ph: (808) 621-6511 |
| NPI Number | 1407094808 |
|---|---|
| Provider Enumeration Date | 01/23/2009 |
| Last Update Date | 03/04/2020 |
| Medicare PECOS PAC ID | 0143465922 |
|---|---|
| Medicare Enrollment ID | O20130327000232 |
News Archive
Treating throat cancer with intensity modulated radiation therapy (IMRT) can improve the health-related quality of life of patients compared to conventional radiation therapy (CRT), according to a study in the December 1 issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
Deep vein thrombosis (DVT) in pregnant patients is more likely to occur on the left side, and in particular in the left leg, write the authors of a Review article in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/embargo/cmaj091692.pdf.
Eribulin was approved in March 2011 for women with locally advanced or metastasizing breast cancer in whom the disease has progressed despite prior drug therapy.
Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR) today announced OICR is investing $4.6 million over two years in PanCuRx, an initiative that seeks solutions to the high fatality rate of pancreatic cancer.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407094808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Arnold Seid |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1457450033 PECOS PAC ID: 8628989951 Enrollment ID: I20050920001284 |
News Archive
Treating throat cancer with intensity modulated radiation therapy (IMRT) can improve the health-related quality of life of patients compared to conventional radiation therapy (CRT), according to a study in the December 1 issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
Deep vein thrombosis (DVT) in pregnant patients is more likely to occur on the left side, and in particular in the left leg, write the authors of a Review article in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/embargo/cmaj091692.pdf.
Eribulin was approved in March 2011 for women with locally advanced or metastasizing breast cancer in whom the disease has progressed despite prior drug therapy.
Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR) today announced OICR is investing $4.6 million over two years in PanCuRx, an initiative that seeks solutions to the high fatality rate of pancreatic cancer.
› Verified 4 days ago
News Archive
Treating throat cancer with intensity modulated radiation therapy (IMRT) can improve the health-related quality of life of patients compared to conventional radiation therapy (CRT), according to a study in the December 1 issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
Deep vein thrombosis (DVT) in pregnant patients is more likely to occur on the left side, and in particular in the left leg, write the authors of a Review article in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/embargo/cmaj091692.pdf.
Eribulin was approved in March 2011 for women with locally advanced or metastasizing breast cancer in whom the disease has progressed despite prior drug therapy.
Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR) today announced OICR is investing $4.6 million over two years in PanCuRx, an initiative that seeks solutions to the high fatality rate of pancreatic cancer.
› Verified 4 days ago
21st Century Healthcare Llc Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 302 California Ave, Suite 209, Wahiawa, HI 96786 Phone: 808-622-2655 Fax: 808-622-5599 | |
Michael Tubianosa Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 128 Lehua St, Wahiawa, HI 96786 Phone: 808-621-8411 | |
Arnold Seid Md Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 960 Center St Ste 7, Wahiawa, HI 96786 Phone: 808-621-6511 Fax: 808-622-9088 | |
Hinakokea Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 128 Lehua St, Wahiawa, HI 96786 Phone: 808-621-8411 | |
Central Oahu Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 302 California Ave Ste 210, Wahiawa, HI 96786 Phone: 808-927-0183 | |
Island Medical Care Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 410 Kilani Ave, Wahiawa, HI 96786 Phone: 808-594-7845 Fax: 844-285-8853 | |
The Wahiawa Center For Community Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 302 California Ave Ste 106, Wahiawa, HI 96786 Phone: 808-622-1618 Fax: 877-759-6943 |